JP Morgan Chase’s NovoCure NVCR Stock Holding History

JP Morgan Chase’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-20,600	Closed	-$614K	–	7616
2024 Q4	$614K	Sell	20,600 -69,600	-77%	-$1.47M	﹤0.01%	4926
2024 Q3	$1.41M	Buy	+90,200	New	+$1.64M	﹤0.01%	4256
2024 Q1	–	Sell	-2,400	Closed	-$35.8K	–	7743
2023 Q4	$35.8K	Hold	2,400	–	–	﹤0.01%	6108
2023 Q3	$38.8K	Hold	2,400	–	–	﹤0.01%	5879
2023 Q2	$99.6K	Hold	2,400	–	–	﹤0.01%	5463
2023 Q1	$144K	Sell	2,400 -38,900	-94%	-$3.11M	﹤0.01%	5257
2022 Q4	$3.03M	Buy	41,300 +11,100	+37%	+$835K	﹤0.01%	3237
2022 Q3	$2.29M	Hold	30,200	–	–	﹤0.01%	3356
2022 Q2	$2.1M	Sell	30,200 -23,700	-44%	-$1.79M	﹤0.01%	3505
2022 Q1	$4.47M	Buy	+53,900	New	+$3.97M	﹤0.01%	3097
2021 Q1	–	Sell	-62,400	Closed	-$10.8M	–	6254
2020 Q4	$10.8M	Buy	+62,400	New	+$8.54M	﹤0.01%	2150
2020 Q2	–	Sell	-20,000	Closed	-$1.35M	–	5594
2020 Q1	$1.35M	Sell	20,000 -93,000	-82%	-$7.35M	﹤0.01%	3227
2019 Q4	$9.52M	Sell	113,000 -50,000	-31%	-$4.04M	﹤0.01%	2152
2019 Q3	$12.2M	Hold	163,000	–	–	﹤0.01%	1972
2019 Q2	$9.92M	Hold	163,000	–	–	﹤0.01%	2118
2019 Q1	$7.85M	Hold	163,000	–	–	﹤0.01%	2250
2018 Q4	$5.46M	Buy	163,000 +133,000	+443%	+$4.86M	﹤0.01%	2508
2018 Q3	$1.57M	Buy	+30,000	New	+$1.19M	﹤0.01%	3628

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

JP Morgan Chase's NVCR Position: Q1 2026 in Review

JP Morgan Chase increased its NovoCure (NVCR) stake by 131% in Q1 2026, buying an estimated $6.59M and bringing the position to 930,166 shares worth $9.64M. The position accounts for ﹤0.01% of the portfolio, ranked #2709.

JP Morgan Chase first reported a position in NVCR in Q4 2015 and has held it in 36 quarters since. The position peaked at $31.9M in Q4 2020. 223 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

JP Morgan Chase held 930,166 shares of NovoCure worth $9.64M as of Q1 2026.
JP Morgan Chase bought 527,284 NovoCure shares in Q1 2026, an estimated $6.59M.
NovoCure made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #2709 holding.
JP Morgan Chase first reported a position in NovoCure in Q4 2015 and has held it in 36 quarters since.
JP Morgan Chase's NovoCure position peaked at $31.9M in Q4 2020.
223 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.